The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Abstract

Objective:

Using Wakefield’s conceptualization of mental disorder as “harmful mental dysfunction” (Wakefield, Am Psychol, 47, 373–388, 1992), we examined the evidence for including obesity as a mental disorder in DSM-V.

Method:

We searched computer databases and examined reference lists from review articles published in the last 10 years to identify empirical papers relevant to the present review.

Results:

Obesity is a condition of heterogeneous etiology that is harmful for most individuals. However, there is scant evidence that obesity, in general, is caused by mental dysfunction. Although recent work examining the neurocircuitry of energy balance has suggested that mental dysfunction may be involved in the etiology of specific obesity phenotypes, findings are too preliminary to support classification of obesity as a mental disorder. Nevertheless, there is evidence that obesity is related to mental disorder and many of the medications used to treat psychiatric illness.

Discussion:

There is little evidence for including obesity as a mental disorder in DSM-V. However, results confirm the importance of monitoring adiposity routinely among patients with psychiatric illness. © 2009 American Psychiatric Association.

(Reprinted from the International Journal of Eating Disorders 2009; 42:739–753. Co-published by American Psychiatric Association.)

Introduction

Publication of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (i.e., DSM-V) is on the horizon, and there is increasing interest in the role that obesity might play in the psychiatric nomenclature. Studies have documented high rates of obesity among individuals with binge eating disorder, bipolar disorder, major depressive disorder, schizophrenia, and other diagnoses.15 Moreover, there is evidence that obesity negatively impacts illness course and response to treatment in some of these groups.6,7 Epidemiologic studies have found a positive association between obesity and several forms of mental illness in general population samples,811 indicating that comorbidity observed in clinic studies is not simply a detection artifact. Finally, similarities among obesity, drug addiction, and compulsive behaviors have led some observers to conclude that a form of obesity characterized by “compulsive food consumption” (p. 708) should be included as a mental disorder in DSM-V.1214

In this article, we examine the evidence for including obesity as a mental disorder in DSM-V. To this end, we begin by defining what is meant by the term “mental disorder.” Using our selected definition as a guide, we then review the extant literature with an eye to determining whether obesity might be considered a mental disorder. Finally, we consider an alternative approach to incorporating obesity in DSM-V that uses body mass index (BMI) as a dimensional index of adiposity.

What Is a Mental Disorder?

To address the question of whether or how obesity reflects mental disorder, one must first have a clear understanding of how the concept is defined. This is challenging, however, because there is no consensus about what constitutes disorder, as multiple observers have noted.1517 Arguably, the two most influential definitions of mental disorder are those employed by the World Health Organization (WHO) in the ICD-10 Classification of Mental and Behavioral Disorders18 and the American Psychiatric Association (APA) in the various editions of the DSM beginning with DSM-III.19 In ICD-10,18 the term disorder is used to “imply the existence of a clinically recognizable set of symptoms or behavior associated in most cases with distress and with interference with personal functions” (p. 11). The authors further specify that “social deviance or conflict alone, without personal dysfunction should not be included in mental disorder as defined here” (p. 11). Similarly, the most recent edition of the DSM (i.e., DSM-IV-TR)20 conceptualizes mental disorder as a “clinically significant behavioral or psychological syndrome or pattern that occurs in an individual and that is associated with present distress (e.g., a painful symptom) or disability (i.e., impairment in one or more important areas of functioning) or with a significantly increased risk of suffering, death, pain, disability, or an important loss of freedom” (p. xxxi). Like ICD-10, DSM-IV-TR specifies that “deviant behavior” and conflicts between an individual and society cannot be classified as mental disorders unless “the deviance or conflict is a symptom of a dysfunction in the individual” (p. xxxi). Moreover, the clinically significant syndrome or pattern of behavior must not “merely be an expectable and culturally sanctioned response to a particular event,” e.g., the death of a loved one (p. xxxi).

The ICD-10 and DSM definitions make several useful points that are relevant to the question of obesity as a mental disorder. For example, both conceptualizations emphasize that mental disorders involve personal (i.e., within the individual) dysfunction and are associated with distress, disability, or interference in other aspects of an individual’s life. They also distinguish mental disorders from other nonpsychiatric problems in living including conflicts between an individual and society.

Nevertheless, there has been substantial criticism of the leading approaches to conceptualizing mental disorder, especially the approach employed by the various editions of the DSM.17,2123 In particular, the DSM-IV-TR definition of mental disorder is so broad that it may be used to either accept or reject the notion that obesity is a mental disorder. Thus, we turned to the work of Jerome Wakefield whose definition of mental disorder as “harmful mental dysfunction” (p. 384)17 has been proposed for inclusion in DSM-V.24 Specifically, Wakefield notes that although the current DSM definition of mental disorder has a number of strengths, its failure to explicate key constructs such as “dysfunction” leads to a lack of clarity about what does and does not qualify as a mental disorder. For example, DSM-IV-TR states that mental disorders must not be “expectable and culturally sanctioned” responses to events (p. xxxi). However, as Wakefield 17,23 points out, some mental disorders may be quite expectable given the context [e.g., post-traumatic stress disorder (PTSD) following a severe trauma]. Moreover, there are many forms of unexpected, culturally unsanctioned behavior (e.g., bad manners, petty crime) that are not considered to be mental disorders.24

In an effort to improve the validity of the mental disorder construct, Wakefield 17,23 has proposed an alternative definition based on the notion of harmful dysfunction. He writes, “A condition is a mental disorder if and only if (a) the condition causes some harm or deprivation of benefit to the person as judged by the standard’s of the person’s culture, and (b) the condition results from the inability of some mental mechanism to perform its natural function, wherein a natural function is an effect that is part of the evolutionary explanation of the existence and structure of the mental mechanism” (p. 385).17 Wakefield’s concept of “harm” is similar to the distress and interference/disability components of both the ICD-10 and DSM conceptualizations of mental disorder. The requirement that dysfunction be present enables the user to distinguish between unexpected and harmful internal conditions that are not, in fact, disorders (e.g., illiteracy, greed, normal reactions to external stressors) and disordered presentations, which may (e.g., PTSD in response to severe trauma) or may not (e.g., auditory hallucinations related to schizophrenia) be expectable given the circumstances.24 Although some have criticized Wakefield’s conceptualization of mental disorder on various grounds,16,2528 we think that it provides a useful heuristic by which to evaluate the relation of obesity to psychiatric illness and thus have elected to adopt the “harmful mental dysfunction” concept in this article. Of particular relevance is the notion that “dysfunction exists when a person’s internal mechanisms are not able to function in the range of environments for which they were designed” (p. 243) .23 As detailed below, one issue in evaluating obesity as a mental disorder involves determining the extent to which excessive weight gain is due to a dysfunction of internal mechanisms versus a mismatch between properly functioning internal mechanisms and an increasingly obesogenic environment.

Method

Guided by Wakefield’s17,23 conceptualization of mental disorder as harmful mental dysfunction, we identified two major questions to be addressed by this review: (1) is obesity harmful? and (2) is there evidence that obesity is caused by mental dysfunction? To place these questions in the appropriate context, we determined that it was necessary first to provide a brief overview of what is meant by the term “obesity.” Because the literature on the etiology and correlates of obesity is ever-expanding, we began by searching computer databases (e.g., MEDLINE, PsychINFO) for review articles published in the last 10 years in major journals. Reference lists of these articles were then used to identify empirical papers for review. In addition, we conducted targeted searches of computer databases to identify articles relevant to specific research methodologies (e.g., neuroimaging) or specific psychiatric correlates of obesity (e.g., depression, psycho tropic medication). Search terms included, but were not limited to, obesity, overweight, adipose tissue, and body fat distribution combined with etiology, overeating, impulsivity, depression, reward, stress, and neuroimaging. The results of our selective review are presented below.

Results

What Is Obesity?

Obesity refers to an excess of body fat. In the broadest sense, obesity results from an imbalance between energy intake and energy expenditure; that is, when an individual ingests more than the body expends, excess energy intake is stored in body fat cells that enlarge or increase in number. At present, there is no clear division between normal and abnormal levels of fat.29 However, body mass index (BMI), a ratio of weight to height calculated by weight in kilograms divided by the square of height in meters, is widely utilized to define obesity operationally given its robust associations with adiposity (i.e., BMI <18.5, underweight; BMI 18.5–24.9, normal weight; BMI 25–29.9, overweight; BMI ≥30, obese)30 and medical comorbidity.

The prevalence of obesity has been increasing worldwide, and the WHO has estimated that globally there are 300 million obese individuals.31 In the United States, the prevalence of obesity in adults aged 20 years and older doubled between 1980 and 2002, whereas rates in children aged 6–19 years tripled.32 In 2003–2004, 32.2% of US adults and 17.1% of US children and adolescents were obese.32 The prevalence of obesity in the United States varies by racial/ethnic group in women (rates for Non-Hispanic White, Mexican American, and Non-Hispanic Black women are 30%, 42.3%, and 53.9%, respectively), but not men.32 As documented below, the worldwide increase in rates of obesity will have profound health consequences.

Is Obesity Harmful?

There is little question that obesity is harmful for most individuals [but see Ref. 33]. The medical consequences of excess body fat are manifold and can be divided into those due to the added weight of the extra fat (e.g., osteoarthritis) and the metabolic changes associated with adiposity (e.g., diabetes).34 Obesity is a risk factor for cardiovascular disease, diabetes, hypertension, kidney disease, obstructive sleep apnea, osteoarthritis, and several forms of cancer (i.e., colon, breast, esophageal, uterine, ovarian, kidney, and pancreatic).35 The increased rate of mortality among obese persons, relative to lean individuals, is well-documented.36

Obesity also is associated with significant psychosocial impairment. Obese individuals are subject to weight-based stigmatization in a variety of settings,37 and generally report poorer quality of life compared with lean individuals.38 With respect to psychiatric correlates, epidemiologic studies have found positive associations between obesity and mood disorders, anxiety disorders, eating disorders, and personality disorders.811,39 These relationships appear to be especially strong for women40,41 and for individuals with more severe obesity (i.e., BMI ≥ 35),8,10 although associations between excess body fat and psychiatric illness also have been documented in men11 and in more moderately overweight individuals.9 Finally, prospective longitudinal studies have shown that obesity predicts the onset of psychiatric symptoms4245 and vice versa.4648

At a societal level, there are profound economic consequences associated with obesity in the form of direct medical costs and indirect costs (e.g., income lost from decreased productivity, worker absenteeism, restricted activity).49 The health care costs related to obesity were estimated to account for 9.1% of US medical expenses in 1998,50 and if current trends continue, obesity will account for 16% of US health care expenditures by 2030.51 Studies conducted in European Union states also have documented that obesity-related health care accounts for a significant proportion of national health expenditures.52 In consideration of the morbidity and mortality associated with obesity,53 the Council of The Obesity Society recently concluded that obesity should be declared a disease.54

Is There Evidence That Obesity Is caused by Mental Dysfunction?

To consider whether obesity is caused by mental dysfunction, it is necessary first to provide a brief overview of current thinking about the etiology of obesity. Obesity research encompasses work in economics, sociology, epidemiology, nutrition, psychology, and biology, and a complete review is beyond the scope of this article. Nevertheless, there is consensus that the etiology of obesity is multifactorial such that a genetic diathesis interacts in an intricate fashion with individual and environmental factors that promote the expression of a heterogeneous condition. Moreover, there is agreement that given the primacy of nutrition for survival, humans have developed diverse and redundant mechanisms that favor energy intake. In the current US socioeconomic context, which is characterized by the availability of cheap, palatable (i.e., high in sugar and fat) food and a decrease in the amount of physical energy required to sustain survival, the multiple mechanisms that promote energy ingestion are no longer adaptive, but rather promote the development of obesity.55

There have been important advances in genetics and basic work serving to explicate the manifold central and peripheral signals that are involved in the regulation of energy balance in humans (for further information, the reader is referred to reviews of the biology of obesity56 and to the extensive literature that details neural networks5759 and adipose tissue functions60,61). Research from family history and twin studies has documented that 40%–70% of the variance in obesity can be accounted for by genetic factors.62 The identification of several monogenic mutations that cause obesity has helped elucidate etiologic pathways associated with genetic obesity syndromes63; however, these monogenic disorders account only for a small fraction of cases with early onset obesity. The preponderance of evidence indicates that a larger number of genes with small effects, but which occur commonly in the general population, explain most weight variation in humans.64,65 The introduction of genome-wide association studies has promoted the identification of genes associated with ordinary obesity66; for example, common variants in the fat mass and obesity-associate (FTO) gene are related to BMI and hip circumference.67,68 Nevertheless, the impact of these common genetic variants probably will be in influencing individual responses to environmental variables such as type of diet.64 Thus, risk may ultimately be understood best by explicating gene environment interactions that impact appetite, satiety, activity levels, and the biology of fat storage.

Conceptualizations of the complex circuitry that comprises the internal system that regulates energy balance have advanced significantly. Central factors include homeostatic mechanisms in the hypothalamus and brainstem, reward circuitry in limbic and paralimbic structures, and cognitive mechanisms in the prefrontal and association cortices, which interact with peripheral signals from the gut, pancreas, liver, adipose tissue, and muscle.69 Although specific examples of central factors that may relate to potential psychiatric aspects of obesity are considered below, it is important to acknowledge the diversity and redundancy of signals involved in energy balance. The caudal brainstem receives nutrition information from the taste buds and gut and controls the machinery involved in food ingestion. The hypothalamus is the major site for integration of nutrient balance information and coordination of adaptive responding. Cortico-limbic pathways are involved in the interaction with the environment in the procurement and consumption of food.

Finally, it may be useful to think of the etiology of obesity as involving more broadly conceived host and environmental factors.70 Additional host factors may include intrauterine development,71 gut microbiota,72 and sleep.71 Environmental factors include the availability of inexpensive, palatable foods and decreases in physical activity. Recent research also has considered an array of novel environmental factors that may contribute to increasing rates of obesity including viruses,73 toxins,74 drugs,70 and stress.55

In summary, regulation of energy intake is crucial to human survival and consequently is protected by numerous redundant and overlapping central and peripheral processes. Clinical obesity reflects alterations in remarkably complex internal and environmental milieus that combine to form multiple pathways that result in obesity. Given the multiplicity of factors implicated in the etiology of obesity and the diversity of the resulting phenotypes, there is little evidence that supports a conclusion that obesity is a mental disorder. In fact, epidemiological observers have concluded that changes in prevalence rates of obesity may be largely due to modest changes in calorie intake and energy expenditure leading to a shift in population weights.75 For example, if a person’s daily energy intake exceeded expenditure by 100 kcal (e.g., a medium apple), the excess calories would lead to a weight gain of more than 10 pounds in a year.76

Are There Subtypes of Obesity Caused by Mental Dysfunction?

If there is little evidence that obesity, in general, is caused by mental dysfunction, it is possible that dysfunction can be implicated in individual cases of obesity. Moreover, it is possible that there is dysfunction “in the processing of psychological meanings that form the ‘software’ of the brain” (p. 24)24; in other words, neurological processes may be functioning as designed, but it is possible that the connection between these processes and the environment has become mismatched in some obese individuals. Several lines of research have increased interest in the potential dysfunction of central pathways that may be involved in obesity-related eating behavior. To explicate the notion that certain central functions may be involved in promoting or maintaining obesity, we first make a distinction between homeostatic and nonhomeostatic eating.77 Then, we describe research related to two specific central pathways, one associated with homeostatic control of eating behavior and the other associated with nonhomeostatic eating, that serve as exemplars of the potential role of mental dysfunction in the pathophysiology of specific forms of obesity.

Homeostatic Versus Nonhomeostatic Eating

Central factors are involved in every aspect of eating behavior, and for conceptual purposes it is useful to make a distinction between homeostatic and nonhomeostatic eating. Homeostatic eating is governed by a complex neural regulatory feedback system designed to preserve energy balance and protect minimal levels of adiposity.77 The hypothalamus serves to integrate nutrition and other information from orexigenic and anorexigenic peptides that are sensitive to circulating leptin and other hormones and metabolites. Second-order neurons in the paraventricular nucleus of the hypothalamus (PVH) are associated with autonomic and neuroen-docrine functions, in particular, regulation of the hypothalamic-pituitary-adrenal (HPA) axis and stress response.

Nonhomeostatic eating refers to behavior that is initiated in the absence of any energy depletion signal. That is, information from the cortex and limbic system easily overrides hypothalamic regulatory information, and promotes energy ingestion.77,78 As a result, individual differences in responsiveness to food-related cues can markedly affect energy intake. The prefrontal cortex receives information from external and internal sources and translates available homeostatic and external information into behavioral responses. In this regard, the right prefrontal cortex has been implicated in behavioral restraint and self-control79; damage to this area is associated with the “Gourmand” syndrome, which involves excessive intake of palatable food.80 Reward from food, a crucial aspect of nonhomeostatic eating, involves a distributed neural network including the nucleus accumbens and ventral pallidum in the ventral striatum, the ventral tegmental area in the midbrain, and the prefrontal cortex, hippocampus, and amygdala.69 Hedonic processes interact with homeostatic processes, but it is as yet unclear how to operationalize various aspects of the central control of food intake for human studies.

Homeostatic Eating, Stress, and Obesity

The notion that stress-related eating contributes to the development of obesity is not new,81 and there is a diverse body of literature that provides indirect support for this idea. For purposes of this review, we consider evidence that the effects of chronic stress on central functioning may be a driver of human obesity. Observers have hypothesized that the combination of ongoing stress and the wide availability of inexpensive, highly palatable foods promote the development of overeating and obesity, in particular, abdominal obesity, in vulnerable individuals. Specifically, some people may overeat to modulate activity of the chronic stress network and reduce negative affect.82 Thus, although the central mechanisms to cope with stress may be operating as designed, there may be a mismatch between these stress-response mechanisms and the current environment. Here we briefly examine evidence that stress effects on central functioning provide a plausible pathway that contributes to the development of obesity. Almost all available evidence is suggestive, rather than confirmatory, and the human literature is rife with methodological difficulties (in particular, the operationalization of chronic stress, which varies widely across studies). Nevertheless, selected findings from the animal literature and human studies linking stress and obesity are considered in turn.

There is an extensive animal literature that documents that the HPA axis is a crucial mediator of the vertebrate stress response system, which serves to maintain homeostasis and coordinate the organism’s behavioral responses to internal and external threats.83 Findings from this work indicate that although increased secretion of glucocorticoids (GCs) during acute stress inhibits HPA activity and decreases eating, the chronic effects of GCs are excitatory and associated with increased food consumption.82 High concentrations of GCs increase expression of corticotropin-releasing factor (CRF) in the HPA to enable the chronic stress network. Elevated GCs in the presence of insulin drive the intake of highly palatable foods, which mitigates unpleasant affect consequent to stress in the nucleus accumbens and prefrontal cortex.84 Finally, elevated GCs promote the development of abdominal fat depots.82 Animal studies that have manipulated GCs and insulin have documented that the joint presence of high cortisol and high insulin drives preference for fat intake.85 Thus, animal data provide suggestive evidence that stress-induced eating occurs in animals and a similar phenomenon may occur in humans.

Numerous human studies have examined the impact of stress on eating. Greeno and Wing,86 in a widely cited review, presented evidence for individual differences in stress-induced eating, and concluded that restrained eating predicts stress-induced eating in women. However, they documented the absence of direct tests of the hypothesis that stress leads to weight gain or the development of obesity. Epel et al. in a series of studies (see Ref. 87 for review), documented that individuals who responded to laboratory stressors with high levels of cortisol were likelier than low cortisol responders to ingest more calories after the stressor. In a subsequent field study, they demonstrated that daily stressors were related to greater intake of snack foods among high cortisol responders.88 However, if stress-related eating drives human obesity one would expect differences between obese and lean individuals in stress-related eating. Torres and Nowson89 reviewed several early studies comparing obese and lean individuals. Only one investigation90 documented increased calorie intake in response to stress among obese compared with lean persons.

Several prospective studies have examined whether stress is associated with weight gain over time. For example, Van Strien et al.91 examined the hypothesis that low emotional eaters would gain less weight in response to negative life events than high emotional eaters. Only male emotional eaters who experienced several negative life events exhibited greater increases in BMI over a 6-month period. In a study of more than 5,000 Finnish twin pairs, Korkeila et al.92 examined the effects of baseline stress on the odds of substantial weight gain (more than 10 kg) at 6- and 15-year assessments. High levels of stress at baseline predicted major weight gain in men whereas neuroticism and low life satisfaction predicted weight gain in women. These effects were observed at 6 years, but were attenuated at 15 years. Finally, data from the Whitehall II study, which included almost 8,000 male and female British workers, were utilized to evaluate whether work stress had a differential effect on weight gain among lean and overweight individuals.93 Results indicated that work stress was associated with subsequent weight gain among overweight and obese men, and weight loss among lean men. These bi-directional associations were not observed in women.

In another line of research, Bjorntorp and colleagues9496 have hypothesized that psychosocial stress may lead to chronic arousal of the HPA axis and increased cortisol secretion, which in turn promote increased insulin resistance, disturbed lipid and glucose metabolism, and accumulation of visceral fat. The approach taken in this work has been to identify psychosocial or socioeconomic handicaps and then to document increased cortisol secretion or HPA perturbations, and visceral and overall adiposity (see Ref. 97 and 98 for reviews). A review of this literature97 concluded that although most of the available data are circumstantial, there is evidence that the HPA and other central regulatory systems are involved in the development of obesity.

Taken collectively, there is suggestive evidence that there may be a sub-group of stress-responsive obese individuals with a diathesis to overeat palatable food and gain weight over time. However, there is scant evidence that such obesity-related overeating should be considered a mental disorder. Rather, it probably is most useful to consider whether obese individuals with frankly aberrant eating patterns, such as those with binge eating disorder, differ in stress-responsivity and associated overeating from obese individuals without aberrant eating. Although early work comparing obese binge eaters to obese nonbinge eaters on dexamethasone suppression found little support for this hypothesis,99,100 studies using neuroimaging or other more recently developed laboratory paradigms may shed additional light on the associations among stress-responsivity, obesity, and aberrant eating.

Nonhomeostatic Eating, Reward, and Obesity

Several recent models have emphasized the role of the neural reward system in the development and maintenance of obesity. Specifically, this research hypothesizes that dysfunction of brain reward circuitry in response to food cues may predispose some individuals to obesity via an increased likelihood of overeating, particularly excessive consumption of palatable foods. For example, as noted in Devlin’s101 review of the potential role of obesity in DSM-V, the notion that some human obesity may result from food “addiction” has gained increased credence. Numerous observers have documented parallels between addictive behaviors and particular forms of overeating,102,103 and more generally have conceptualized addiction as a process that occurs when any habitual behavior (e.g., eating, gambling) co-opts brain reward circuitry.104 Work by Volkow and colleagues12,14,105,106 has explicated the similarities between drug addiction and obesity, such as decreased levels of striatal dopamine D2 receptors, and suggested that obesity, like drug addiction, is linked with exposure to and reward from powerful reinforcers (i.e., food).

Current conceptualizations of food hedonics or reward distinguish between wanting, i.e., the desire for or motivation to consume foods and liking, i.e., the degree of pleasure derived from food consumption (see Ref. 107 for review). In terms of wanting food, obese individuals may differentially seek food or respond in a heightened way to food cues. In terms of liking food, obese individuals may have a heightened hedonic response to food, and thus overeat. Conversely, obese individuals may have less pleasure from food, and consequently eat more highly palatable food to optimize pleasure. Neurobiological models also emphasize the role of learning in reward, noting that cognitive processes interact with motivational and affective mechanisms to influence reward.108 A comprehensive examination of the research literature that examines food reward is beyond the scope of this article. Much of this work has focused on animals (see Refs. 109–112 for review), but there are several lines of research in human subjects that provide at least indirect support for the proposition that differences in reward neurocircuitry are involved in overeating associated with obesity.

For example, studies have examined human differences in sensitivity to reward (STR), a trait thought to be linked to the mesolimbic dopamine pathway. Davis et al.113 measured STR by questionnaire and found that it was associated with emotional overeating in response to depressed mood and BMI in women. Similarly, research using functional magnetic resonance imaging (fMRI) has shown that healthy volunteers who self-report higher STR demonstrate greater activation in the frontal-striatal-amygdala-midbrain network in response to appetizing foods.114 These findings are suggestive of an association between reward sensitivity and eating behavior. However, investigations that rely on self-report of reward sensitivity or that do not include comparisons of obese and lean individuals do not provide direct evidence that obese persons differ from their normal weight counterparts in hedonic responses to food.

There is a burgeoning literature comparing obese and lean individuals on measures of neural activation in response to food stimuli or neural correlates of food reward using neuroimaging techniques [i.e., positron emission tomography (PET), MRI, fMRI]. As reviewed in Supporting Information Table S1 (see Supporting Information on Wiley-Interscience), in general, this work suggests that relative to lean individuals, obese persons have increased activation to anticipated food reward (i.e., increased wanting) and decreased activation to food consumption (i.e., decreased liking), although specific findings have varied across studies.

Several reports have shown that exposure to palatable food stimuli, which may activate processes related to food wanting, is associated with greater neural activation among obese compared with lean individuals. For example, Karhunen et al.115 found that obese women had increased activation in the right parietal and temporal cortices relative to normal-weight women in response to viewing, but not eating, a heated meal. Similarly, Rothemund et al.116 reported that obese women had greater activation in the dorsal striatum, anterior insula, hippocampus, and parietal lobule than did lean women in response to viewing pictures of high-calorie foods. Stoeckel et al.117 also found evidence of increased activation in the dorsal striatum, insula, and hippocampus, as well several other brain regions, in obese women relative to normal-weight controls while viewing high-calorie food images. Taken together, these findings provide support for the notion that obese individuals experience increased neural reactivity to palatable food cues, which may suggest the presence of heightened motivation for eating in this group. However, the results from one recent study suggest that these differences may be specific to obese individuals with comorbid binge eating,118 which raises questions about the extent to which increased neural activation to food cues among obese persons is explained by higher rates of eating pathology in this group.

Research also has found differences between obese and lean individuals with respect to neural activation in response to tasting and consuming food. For example, in a series of studies using PET scans and MRI to examine neural responses to food reward in the context of extreme hunger (i.e., following a 36-h fast), Gautier, Del Parigi and colleagues119122 documented that obese individuals exhibit increased activation in the prefrontal cortex (but see Ref. 122) and frontal operculum and decreased activation in the hippocampus, amygdala, cingulate cortex (but see Ref. 120), caudate nucleus, and putamen relative to lean controls in response to consuming a satiating liquid meal (i.e., 50% of estimated daily expenditure in the form of Ensure). Furthermore, in response to tasting a small quantity (i.e., 2 mL) of the liquid meal prior to full consumption, obese individuals showed increased activation in the insular cortex and midbrain compared with lean controls.119,123 Of note, insular activity in response to anticipated food reward (i.e., a satiating meal in the context of extreme hunger) remained present in formerly obese individuals119 and was correlated with disinhibition.123

Recent work has distinguished the neural correlates of anticipatory and consummatory food reward in obese and lean individuals. Stice et al.124 found that obese relative to lean adolescent girls exhibited greater activation in the insular cortex, anterior cingulate cortex, and somatosensory cortex (i.e., Rolandic operculum, temporal operculum, parietal operculum) in response to cues signaling impending delivery of palatable food. In response to receipt of the palatable food, obese adolescents showed increased activation in the Rolandic operculum and left-frontal operculum compared to lean controls. Moreover, continuous analyses found a negative association between BMI and activity in the caudate nucleus in response to consummatory food reward, which is consistent with research indicating that obese individuals have reduced striatal dopamine receptor availability relative to lean persons and thus may experience diminished reward from eating.13,105 Indeed, a follow-up study documented that presence of the TaqIA A1 allele, which is associated with reduced dopamine D2 receptor gene binding in the striatum, moderated the relation between blunted striatal activation to consummatory food reward and BMI currently and at 1-year follow-up in adolescent and adult females125 (Prospective analyses conducted only in adolescent females—see Supporting Information Table S1).

In summary, there is accumulating evidence that obese individuals differ from lean controls with respect to neural correlates of anticipated food reward and food consumption. These findings may suggest that mental mechanisms related to reward processing play a role in the onset and maintenance of obesity. However, as noted in Supporting Information Table S1, a number of questions remain unanswered regarding the presence of mental dysfunction related to reward circuitry in obese persons. First, although studies have documented differences between obese and lean individuals in neural responses to food stimuli, no research to date has provided conclusive evidence that these differences represent dysfunction, i.e., “the inability of some mental mechanism to perform its natural function” (p. 385).17 Indeed, it is entirely possible that observed differences reflect normal variation in reward sensitivity that historically conferred an adaptive advantage, but no longer is adaptive in an obesogenic environment. Second, with the exception of one recent study125 that documented that decreased striatal activation to consummatory food reward is associated with increases in BMI among adolescent females with the TaqIA A1 allele, no research has provided evidence that differences in neural activation in response to food reward are associated with the onset or maintenance of obesity. It seems equally plausible that observed differences may be a consequence or correlate of obesity. Third, although many investigators have hypothesized that activation of reward circuitry is related to overeating among obese individuals, no study has provided direct evidence that differences between obese and lean persons with respect to neural correlates of food reward are associated with in vivo eating behavior. Finally, studies focusing on reward processing in obese versus lean individuals typically have made little or no distinction for other behavioral or physiologic phenotypes that might refine our understanding of differences between these groups.1 “Obese” and “lean” persons represent large and heterogeneous segments of the population. Moreover, as noted above, at least one report has suggested that differences in neural activation between obese and lean women in response to palatable food cues may be due to higher rates of eating-related psychopathology among obese persons.118 If replicated, this work might suggest that mental dysfunction, if present among obese individuals, is limited to those with coexisting eating pathology.

Discussion

Using a definition of mental disorder based on the notion of harmful dysfunction,17,23 we conclude that there is insufficient evidence for the inclusion of obesity in DSM-V. Although future work may well document central dysfunction in the pathogenesis of specific obesity phenotypes, current data do not support the idea that obesity is a mental disorder. Nevertheless, there are many reasons to consider adiposity in the assessment of psychiatric illness. Below we briefly present three lines of evidence bearing on the clinical significance of obesity in psychiatric diagnosis: (1) the relation between disordered eating and obesity; (2) the relation between other psychiatric syndromes and obesity; and (3) the iatrogenic effects of psychotropic medications on weight gain and adiposity. We then close by summarizing the results of the present review and offering our recommendations for the inclusion of BMI (as an index of adiposity) in the assessment and management of psychiatric illness.

Disordered Eating and Obesity

Current evidence has implicated increases in energy intake (i.e., eating) as opposed to decreases in energy expenditure (i.e., physical activity) as the major contributor to the rise in obesity prevalence.126,127 Although there are many factors that lead to increased energy intake, one potential contributor to weight gain among a subgroup of the obese population is disordered eating behavior. Epidemiologic studies have documented an association between disordered eating, particularly binge eating (i.e., episodes of uncontrolled overeating), and obesity.8,128,129 For example, an investigation utilizing the cohort from the Coronary Artery Risk Development in Young Adults (CARDIA) study, found higher rates of self-reported binge eating disorder (BED) among overweight participants (defined as BMI ≥ 27.3 in women or ≥27.8 in men) than among the cohort as a whole (3.0% versus 1.5%).129 Similarly, recent data from the National Comorbidity Survey Replication (NCS-R) showed a robust association between BED ascertained by structured diagnostic interview and severe obesity (BMI ≥ 40).8 Finally, evidence from sequential general population surveys in Australia indicates that rates of comorbid obesity and eating disorder behaviors (primarily binge eating) increased from 1% to 3.5% in the period between 1995 and 2005.128

At present, psychiatric problems with eating are included in the DSM under Eating Disorders, which “are characterized by severe disturbances in eating behavior” (p. 583).20 The Eating Disorders Work Group of the DSM-V Task Force is examining the current classification, which provides an opportunity to consider the role of obesity-related eating behaviors in DSM-V. Adiposity is included explicitly and implicitly in the current Eating Disorders. For example, anorexia nervosa (AN) is characterized by the inability to maintain a minimally adequate body weight and extreme dietary restriction, while bulimia nervosa (BN) is characterized by binge eating paired with compensatory behaviors to undo the effects of overeating and presumably avoid undesirable weight gain. BED, a type of eating disorder not otherwise specified that is included as a provisional diagnosis for further study in DSM-IV-TR, also is characterized by recurrent binge eating, but without the regular compensatory behaviors seen in BN. Most, but not all, individuals with BED are overweight or obese.20 Thus, there already is a place in the DSM for obesity phenotypes characterized by aberrant eating.101 Nevertheless, given the relationship between binge eating, particularly BED, and adiposity, as well as the clinical salience of obesity, we recommend that BMI be included routinely in any assessment of disordered eating.

Other Psychiatric Syndromes and Obesity

It also is important to acknowledge the extensive literature linking obesity to non-eating-related mental disorders. This work is complex, and available data suggest that associations between obesity and psychiatric illness likely are moderated by numerous factors including degree of adiposity, type of psychiatric symptomatology, and population studied (e.g., males versus females, clinic versus community sample). Results from selected studies that have evaluated the cross-sectional association between obesity and mental disorders are presented in Supporting Information Table S2. Because an exhaustive review of this literature is beyond the scope of this article, we focus primarily on studies conducted in epidemiologic or community samples, as these data are not confounded by the effects of treatment-seeking status on rates of co-occurrence between medical conditions. Although differences in methodology make it somewhat difficult to draw definitive conclusions from this body of work, in general, current evidence suggests that there is a positive association between adiposity and mental disorder (Supporting Information Table S2) (but see Refs. 130–132).

For example, using data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), Petry et al.9 found that obese (BMI = 30–39.9) and extremely obese (BMI ≥ 40) individuals were more likely than normal-weight (BMI = 18.5–24.9) persons to be diagnosed with a mood disorder, anxiety disorder, alcohol use disorder, or personality disorder. Similar findings were reported by a study using data from the NCS-R. Specifically, Simon et al.11 documented positive, albeit modest (odds ratios = 1.1–1.6), associations between obesity (BMI ≥ 30) and current and lifetime mood and anxiety disorders. However, rates of substance use disorder were reduced in obese persons relative to normal-weight controls. Finally, emerging evidence supports a positive link between obesity and attention-deficit-hyperactivity disorder (ADHD) in children and adults.133,134

The exact causes for the comorbidity of obesity and non-eating-related mental disorders remain unknown. However, there are several possible explanations that provide support for the clinical utility of considering BMI in the assessment of psychiatric illness. For example, obesity shares a number of symptomatic features in common with psychiatric disorders including increased appetite, decreased activity levels, and sleep disturbance. Indeed, changes in weight status or eating behavior are DSM-IV-TR criteria for major depressive episodes, dysthymia, and borderline personality disorder.20 Furthermore, clinical observers have suggested that obese individuals display behaviors characteristic of addictive disorders14 and impulse-control disorders.135,136 Obesity also shares a number of correlates in common with mental disorders including biological abnormalities (e.g., HPA axis dysregulation, dopamine dysfunction)14,137 and environmental precipitants (e.g., childhood trauma).138141 Thus, it is possible that increased adiposity in psychiatric patients may signal the presence of a clinically relevant third variable that could influence decisions about assessment and treatment planning. Finally, prospective longitudinal research indicates that there is a bidirectional association between obesity and mental disorder. In particular, current data suggest that the presence of psychiatric symptoms, particularly depression, increases the likelihood of developing obesity4648 and obesity-related medical comorbidities (e.g., cardiovascular disease, diabetes, metabolic syndrome)142144 and vice versa.4345,142,145

The Iatrogenic Effects of Psychotropic Medication

A third reason to consider BMI and obesity routinely in psychiatric assessment is the potential impact of psychotropic drugs on body weight, which has been linked to medication noncompliance and the development of obesity-related comorbidities.146 The majority of currently available psychiatric medications will lead to weight gains of 2–17 kg over the course of treatment.147 Antipsychotic drugs (in particular, several second generation antipsychotic agents), antidepressants (especially tricyclics), and mood stabilizers (e.g., valproate and lithium) all are known to cause weight gain. In contrast, there are only a few medications that appear to be weight neutral (e.g., ziprasidone, lamotrigine) or associated with weight loss (e.g., topiramate, bupropion).147 Because psychiatric medications affect multiple and diverse aspects of central functioning, there is no single cause of psychotropic-associated weight gain (see Refs. 148 and 149 for review). Furthermore, iatrogenic weight gain varies as a function of pharmacologic agent, psychiatric disorder, and individual patient factors.147

There has been a particular focus on the potential iatrogenic effects of second generation antipsychotic medications, especially clozapine and olanzapine.150 For example, in one meta-analysis, clozapine and olanzapine were associated with weight gains of 4.5 kg and 4.0 kg, respectively, over a period of 10 weeks.151 Moreover, use of these agents is associated with cardiovascular disease risk factors,152,153 metabolic syndrome,150 and diabetes.154

Data documenting the effects of psychiatric medications on the development of obesity and associated medical comorbidities underline the importance of choosing psychiatric medications carefully and monitoring their effects to facilitate early identification and treatment of associated medical problems.148 Most importantly these data provide another reason why it is critical for clinicians to monitor BMI systematically in patients with psychiatric disorders.

Final Summary and Recommendations

In summary, this article sought to evaluate current evidence that obesity, defined as an excess of body fat, should be included as a mental disorder in DSM-V. Guided by Wakefield’s conceptualization of mental disorder as “harmful mental dysfunction” (p. 384),17 we identified two major criteria that need to be fulfilled in order for obesity to be considered a mental disorder: (1) there must be evidence that obesity is harmful; and (2) there must be evidence that obesity is caused by mental dysfunction. With respect to the first criterion, we conclude that there is evidence that obesity is harmful for many, if not most, individuals. Although a few scholars have questioned the public health significance of the findings,33 a large body of research has documented that obesity is associated with increased rates of medical34,35 and psychiatric811 morbidity. Furthermore, there is evidence that obesity presents a significant economic burden for society.4952

However, with respect to the second criterion, we find little evidence to support the notion that obesity is caused by mental dysfunction. The etiology of obesity is complex and reflects alterations in numerous internal and environmental milieus. Moreover, epidemiological observers have concluded that recent changes in the prevalence of obesity are due, in large part, to modest changes in calorie intake and energy expenditure,75 which does not support the idea that obesity is a mental disorder. Nevertheless, it is possible that mental dysfunction might be involved in the development of certain obesity phenotypes. We presented two such exemplars, one related to homeostatic eating (i.e., stress-induced obesity) and the other to non-homeostatic eating (i.e., reward-associated obesity), and examined available evidence in support of these pathways. Although some data are suggestive of obesity-related mental dysfunction, these findings are preliminary. Of note, future work is needed to address the extent to which mental dysfunction, when present in obese individuals, may be explained by coexisting psychopathology (e.g., binge eating, depression).

If there is little evidence to support the classification of obesity as a mental disorder in DSM-V, there are many reasons to consider adiposity in the assessment and management of psychiatric illness. We reviewed three lines of research bearing on the clinical significance of obesity in mental disorder: (1) the relation between disordered eating and obesity; (2) the relation between other psychiatric syndromes and obesity; and (3) the iatrogenic effects of psychotropic medication on weight gain and adiposity. On the basis of our findings, we make the following recommendations for the inclusion of adiposity in DSM-V: First, given the documented association between obesity and binge eating,8,128,129 as well as the relation of adiposity to other disordered eating symptoms (e.g., extreme dietary restriction), we recommend that BMI be added as a dimensional assessment for all Eating Disorders. Second, because obesity is associated with a broad range of psychiatric disorders9,134 and there is evidence that many of the drugs used to treat psychiatric illness lead to weight gain,147 we recommend that clinicians monitor BMI routinely in all patients with mental disorders, particularly those taking psychotropic mediations, and refer individuals with marked increases in weight for additional medical assessment. These approaches will facilitate medical monitoring of psychiatric patients and stimulate future research.

References

1. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: Findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005;7:424–430.CrossrefGoogle Scholar

2. McElroy SL, Frye MA, Suppes T, Dhavale D, Keck PEJr, Leverich GS, et al.. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207–213.CrossrefGoogle Scholar

3. Papakostas GI, Petersen T, Iosifescu DV, Burns AM, Nierenberg AA, Alpert JE, et al.. Obesity among outpatients with major depressive disorder. Int J Neuropsychopharmacol 2005;8:59–63.CrossrefGoogle Scholar

4. Susce MT, Villanueva N, Diaz FJ, de Leon J. Obesity and associated complications in patients with severe mental illnesses: A cross-sectional survey. J Clin Psychiatry 2005;66:167–173.CrossrefGoogle Scholar

5. Pike KM, Dohm FA, Striegel-Moore RH, Wilfley DE, Fairburn CG. A comparison of black and white women with binge eating disorder. Am J Psychiatry 2001;158:1455–1460.CrossrefGoogle Scholar

6. Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003;160:112–117.CrossrefGoogle Scholar

7. Kloiber S, Ising M, Reppermund S, Horstmann S, Dose T, Majer M, et al.. Overweight and obesity affect treatment response in major depression. Biol Psychiatry 2007;62:321–326.CrossrefGoogle Scholar

8. Hudson JI, Hiripi E, Pope HGJr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007;61:348–358.CrossrefGoogle Scholar

9. Petry NM, Barry D, Pietrzak RH, Wagner JA. Overweight and obesity are associated with psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med 2008;70:288–297.CrossrefGoogle Scholar

10. Scott KM, Bruffaerts R, Simon GE, Alonso J, Angermeyer M, de Girolamo G, et al.. Obesity and mental disorders in the general population: Results from the world mental health surveys. Int J Obes 2008;32:192–200.CrossrefGoogle Scholar

11. Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, et al.. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 2006;63:824–830.CrossrefGoogle Scholar

12. Volkow ND, O’Brien CP. Issues for DSM-V: Should obesity be included as a brain disorder? Am J Psychiatry 2007;164:708–710.CrossrefGoogle Scholar

13. Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, et al.. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factors. Neuroimage 2008;42:1537–1543.CrossrefGoogle Scholar

14. Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci 2005;8:555–560.CrossrefGoogle Scholar

15. Clark LA. Introduction to the special section on the concept of disorder. J Abnorm Psychol 1999;108:371–373.CrossrefGoogle Scholar

16. Lilienfeld SO, Marino L. Mental disorder as a Roschian concept: A critique of Wakefield’s “harmful dysfunction” analysis. J Abnorm Psychol 1995;104:411–420.CrossrefGoogle Scholar

17. Wakefield JC. The concept of mental disorder. On the boundary between biological facts and social values. Am Psychol 1992;47:373–388.CrossrefGoogle Scholar

18. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992.Google Scholar

19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Association, 1980.Google Scholar

20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th, text revision ed. Washington, DC: American Psychiatric Association, 2000.Google Scholar

21. Crowe M. Constructing normality: A discourse analysis of the DSM-IV. J Psychiatr Ment Health Nurs 2000;7:69–77.CrossrefGoogle Scholar

22. Thakker J, Ward T, Strongman KT. Mental disorder and cross-cultural psychology: A constructivist perspective. Clin Psychol Rev 1999;19:843–874.CrossrefGoogle Scholar

23. Wakefield JC. Disorder as harmful dysfunction: A conceptual critique of DSM-III-R’s definition of mental disorder. Psychol Rev 1992;99:232–247.CrossrefGoogle Scholar

24. Wakefield JC, First MB. Clarifying the distinction between disorder and nondisorder. Confronting the overdiagnosis (false-positives) problem in DSM-V. In: Phillips KA, First MB, Pincus HA, editors. Advancing DSM Dilemmas in Psychiatric Diagnosis. Washington, DC: American Psychiatric Association, 2003, pp. 23–55.Google Scholar

25. Kirmayer LJ, Young A. Culture and context in the evolutionary concept of mental disorder. J Abnorm Psychol 1999;108:446–452.CrossrefGoogle Scholar

26. McNally RJ. On Wakefield’s harmful dysfunction analysis of mental disorder. Behav Res Ther 2001;39:309–314.CrossrefGoogle Scholar

27. Richters JE, Hinshaw SP. The abduction of disorder in psychiatry. J Abnorm Psychol 1999;108:438–445.CrossrefGoogle Scholar

28. Sadler JZ. Horsefeathers: A commentary on “evolutionary versus prototype analyses of the concept of disorder”. J Abnorm Psychol 1999;108:433–437.CrossrefGoogle Scholar

29. Ogden CL, Carroll MD, Flegal KM. Epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am 2003;32:741–760, vii.CrossrefGoogle Scholar

30. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes Res 1998;6 (Suppl 2):51S–209S.CrossrefGoogle Scholar

31. World Health Organization. Global strategy on diet, physical activity and health. Obesity and overweight. 2003 [updated 2003; cited]; Available from: http://www.who.Google Scholar

32. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549–1555.CrossrefGoogle Scholar

33. Campos P, Saguy A, Ernsberger P, Oliver E, Gaesser G. The epidemiology of overweight and obesity: Public health crisis or moral panic? Int J Epidemiol 2006;35:55–60.CrossrefGoogle Scholar

34. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004;89:2583–2589.CrossrefGoogle Scholar

35. Eckel RH. Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med 2008;358:1941–1950.CrossrefGoogle Scholar

36. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007;132:2087–2102.CrossrefGoogle Scholar

37. Puhl RM, Brownell KD. Confronting and coping with weight stigma: An investigation of overweight and obese adults. Obesity 2006;14:1802–1815.CrossrefGoogle Scholar

38. Marcus MD. Effects of obesity on the quality of life. 2002 [updated 2002; cited]; Available from: http://www.endotext.com.Google Scholar

39. Pickering RP, Grant BF, Chou SP, Compton WM. Are overweight, obesity, and extreme obesity associated with psychopathology? Results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2007;68:998–1009.CrossrefGoogle Scholar

40. Barry D, Pietrzak RH, Petry NM. Gender differences in associations between body mass index and DSM-IV mood and anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions. Ann Epidemiol 2008;18:458–466.CrossrefGoogle Scholar

41. McIntyre RS, Konarski JZ, Wilkins K, Soczynska JK, Kennedy SH. Obesity in bipolar disorder and major depressive disorder: Results from a national community health survey on mental health and well-being. Can J Psychiatry 2006;51:274–280.CrossrefGoogle Scholar

42. Anderson SE, Cohen P, Naumova EN, Jacques PF, Must A. Adolescent obesity and risk for subsequent major depressive disorder and anxiety disorder: Prospective evidence. Psychosom Med 2007;69:740–747.CrossrefGoogle Scholar

43. Herva A, Laitinen J, Miettunen J, Veijola J, Karvonen JT, Laksy K, et al.. Obesity and depression: Results from the longitudinal Northern Finland 1966 Birth Cohort Study. Int J Obes 2006;30:520–527.CrossrefGoogle Scholar

44. Kasen S, Cohen P, Chen H, Must A. Obesity and psychopathology in women: A three decade prospective study. Int J Obes 2008;32:558–566.CrossrefGoogle Scholar

45. Roberts RE, Deleger S, Strawbridge WJ, Kaplan GA. Prospective association between obesity and depression: Evidence from the Alameda County Study. Int J Obes Relat Metab Disord 2003;27:514–521.CrossrefGoogle Scholar

46. Franko DL, Striegel-Moore RH, Thompson D, Schreiber GB, Daniels SR. Does adolescent depression predict obesity in black and white young adult women? Psychol Med 2005;35:1505–1513.CrossrefGoogle Scholar

47. Hasler G, Pine DS, Kleinbaum DG, Gamma A, Luckenbaugh D, Ajdacic V, et al.. Depressive symptoms during childhood and adult obesity: The Zurich Cohort Study. Mol Psychiatry 2005;10:842–850.CrossrefGoogle Scholar

48. Richardson LP, Davis R, Poulton R, McCauley E, Moffitt TE, Caspi A, et al.. A longitudinal evaluation of adolescent depression and adult obesity. Arch Pediatr Adolesc Med 2003;157:739–745.CrossrefGoogle Scholar

49. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998;6:97–106.CrossrefGoogle Scholar

50. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: How much, and who’s paying? Health Aff (Millwood). 2003 Jan-Jun;Suppl Web Exclusives:W3-219–26.Google Scholar

51. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 2008;16:2323–2330.CrossrefGoogle Scholar

52. Fry J, Finley W. The prevalence and costs of obesity in the EU. Proc Nutr Soc 2005;64:359–362.CrossrefGoogle Scholar

53. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al.. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763–778.CrossrefGoogle Scholar

54. Obesity as a disease: The Obesity Society Council resolution. Obesity 2008;16:1151.CrossrefGoogle Scholar

55. Kral JG. The pathogenesis of obesity: Stress and the brain-gut axis. Surg Obes Relat Dis 2005;1:25–34.CrossrefGoogle Scholar

56. Trayhurn P. The biology of obesity. Proc Nutr Soc 2005;64:31–38.CrossrefGoogle Scholar

57. Berthoud HR. Interactions between the “cognitive” and “metabolic” brain in the control of food intake. Physiol Behav 2007;91:486–498.CrossrefGoogle Scholar

58. Cohen DA. Neurophysiological pathways to obesity: Below awareness and beyond individual control. Diabetes 2008;57:1768–1773.CrossrefGoogle Scholar

59. Levin BE. Factors promoting and ameliorating the development of obesity. Physiol Behav 2005;86:633–639.CrossrefGoogle Scholar

60. Ahima RS, Qi Y, Singhal NS, Jackson MB, Scherer PE. Brain adipocytokine action and metabolic regulation. Diabetes 2006;55(Suppl 2): S145–S154.CrossrefGoogle Scholar

61. Scherer PE. Adipose tissue: From lipid storage compartment to endocrine organ. Diabetes 2006;55:1537–1545.CrossrefGoogle Scholar

62. Barsh GS, Farooqi IS, O’Rahilly S. Genetics of body-weight regulation. Nature 2000;404:644–651.CrossrefGoogle Scholar

63. Farooqi IS, O’Rahilly S. Monogenic obesity in humans. Annu Rev Med 2005;56:443–458.CrossrefGoogle Scholar

64. Farooqi S, O’Rahilly S. Genetics of obesity in humans. Endocr Rev 2006;27:710–718.CrossrefGoogle Scholar

65. Wardle J, Carnell S, Haworth CM, Plomin R. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr 2008;87:398–404.CrossrefGoogle Scholar

66. Bergman RN. What for genetics? Obesity 2008;16:507–508.CrossrefGoogle Scholar

67. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, et al.. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007;3:e115.CrossrefGoogle Scholar

68. Villalobos-Comparan M, Teresa Flores-Dorantes M, Teresa Villarreal-Molina M, Rodriguez-Cruz M, Garcia-Ulloa AC, Robles L, et al.. The FTO gene is associated with adulthood obesity in the Mexican population. Obesity 2008;16:2296–2301.CrossrefGoogle Scholar

69. Lenard NR, Berthoud HR. Central and peripheral regulation of food intake and physical activity: Pathways and genes. Obesity 2008;16(Suppl 3):SS11–SS22.CrossrefGoogle Scholar

70. Bray GA, Champagne CM. Beyond energy balance: There is more to obesity than kilocalories. J Am Diet Assoc 2005;105 (Suppl 1):S17–S23.CrossrefGoogle Scholar

71. Eisenmann JC. Insight into the causes of the recent secular trend in pediatric obesity: Common sense does not always prevail for complex, multi-factorial phenotypes. Prev Med 2006;42:329–335.CrossrefGoogle Scholar

72. DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008;83:460–469.CrossrefGoogle Scholar

73. Atkinson RL. Viruses as an etiology of obesity. Mayo Clin Proc 2007;82:1192–1198.CrossrefGoogle Scholar

74. Keith SW, Redden DT, Katzmarzyk PT, Boggiano MM, Hanlon EC, Benca RM, et al.. Putative contributors to the secular increase in obesity: Exploring the roads less traveled. Int J Obes 2006;30:1585–1594.CrossrefGoogle Scholar

75. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health 2007;121:492–496.CrossrefGoogle Scholar

76. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med 1997;337:396–407.CrossrefGoogle Scholar

77. Berthoud HR. Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance. Obesity 2006;14(Suppl 5):197S–200S.CrossrefGoogle Scholar

78. Yeomans MR, Blundell JE, Leshem M. Palatability: Response to nutritional need or need-free stimulation of appetite? Br J Nutr 2004;92(Suppl 1):S3–S14.CrossrefGoogle Scholar

79. Alonso-Alonso M, Pascual-Leone A. The right brain hypothesis for obesity. JAMA 2007;297:1819–1822.CrossrefGoogle Scholar

80. Uher R, Treasure J. Brain lesions and eating disorders. J Neurol Neurosurg Psychiatry 2005;76:852–857.CrossrefGoogle Scholar

81. Kaplan HI, Kaplan HS. The psychosomatic concept of obesity. J Nerv Ment Dis 1957;125:181–201.CrossrefGoogle Scholar

82. Dallman MF, Pecoraro N, Akana SF, La Fleur SE, Gomez F, Houshyar H, et al.. Chronic stress and obesity: A new view of “comfort food”. Proc Natl Acad Sci USA 2003;100:11696–11701.CrossrefGoogle Scholar

83. Pecoraro N, Dallman MF, Warne JP, Ginsberg AB, Laugero KD, la Fleur SE, et al.. From Malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants. Prog Neurobiol 2006;79:247–340.CrossrefGoogle Scholar

84. Dallman MF, Pecoraro NC, la Fleur SE. Chronic stress and comfort foods: Self-medication and abdominal obesity. Brain Behav Immun 2005;19:275–280.CrossrefGoogle Scholar

85. la Fleur SE, Akana SF, Manalo SL, Dallman MF. Interaction between corticosterone and insulin in obesity: Regulation of lard intake and fat stores. Endocrinology 2004;145:2174–2185.CrossrefGoogle Scholar

86. Greeno CG, Wing RR. Stress-induced eating. Psychol Bull 1994;115:444–464.CrossrefGoogle Scholar

87. Adam TC, Epel ES. Stress, eating and the reward system. Physiol Behav 2007;91:449–458.CrossrefGoogle Scholar

88. Epel E, Lapidus R, McEwen B, Brownell K. Stress may add bite to appetite in women: A laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology 2001;26:37–49.CrossrefGoogle Scholar

89. Torres SJ, Nowson CA. Relationship between stress, eating behavior, and obesity. Nutrition 2007;23:887–894.CrossrefGoogle Scholar

90. Slochower J, Kaplan SP, Mann L. The effects of life stress and weight on mood and eating. Appetite 1981;2:115–125.CrossrefGoogle Scholar

91. Van Strien T, Rookus MA, Bergers GP, Frijters JE, Defares PB. Life events, emotional eating and change in body mass index. Int J Obes 1986;10:29–35.Google Scholar

92. Korkeila M, Kaprio J, Rissanen A, Koshenvuo M, Sorensen TI. Predictors of major weight gain in adult Finns: Stress, life satisfaction and personality traits. Int J Obes Relat Metab Disord 1998;22:949–957.CrossrefGoogle Scholar

93. Kivimaki M, Head J, Ferrie JE, Shipley MJ, Brunner E, Vahtera J, et al.. Work stress, weight gain and weight loss: Evidence for bidirectional effects of job strain on body mass index in the Whitehall II study. Int J Obes 2006;30:982–987.CrossrefGoogle Scholar

94. Bjorntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med Scand Suppl 1988;723:121–134.Google Scholar

95. Bjorntorp P. Abdominal fat distribution and disease: An overview of epidemiological data. Ann Med 1992;24:15–18.CrossrefGoogle Scholar

96. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150–1162.CrossrefGoogle Scholar

97. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2001;2:73–86.CrossrefGoogle Scholar

98. Bjorntorp P, Rosmond R. Obesity and cortisol. Nutrition 2000;16:924–936.CrossrefGoogle Scholar

99. Yanovski JA, Yanovski SZ, Gold PW, Chrousos GP. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss. J Clin Endocrinol Metab 1997;82:1874–1878.CrossrefGoogle Scholar

100. Yanovski SZ, Yanovski JA, Gwirtsman HE, Bernat A, Gold PW, Chrousos GP. Normal dexamethasone suppression in obese binge and nonbinge eaters with rapid weight loss. J Clin Endocrinol Metab 1993;76:675–679.Google Scholar

101. Devlin MJ. Is there a place for obesity in DSM-V? Int J Eat Disord 2007;40(Suppl):S83–S88.CrossrefGoogle Scholar

102. Gearhardt AN, Corbin WR, Brownell KD. Food addiction: An examination of the diagnostic criteria for dependence. J Addict Med 2009;3:1–7.CrossrefGoogle Scholar

103. !Gold MS, Frost-Pineda K, Jacobs WS. Overeating, binge eating, and eating disorders as addictions. Psychiatric Annals 2003;33:117–122.CrossrefGoogle Scholar

104. Holden C. ‘Behavioral’ addictions: Do they exist? Science 2001;294:980–982.CrossrefGoogle Scholar

105. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, et al.. Brain dopamine and obesity. Lancet 2001;357:354–357.CrossrefGoogle Scholar

106. Wang GJ, Yang J, Volkow ND, Telang F, Ma Y, Zhu W, et al.. Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proc Natl Acad Sci USA 2006;103:15641–15645.CrossrefGoogle Scholar

107. Finlayson G, King N, Blundell JE. Liking vs. wanting food: Importance for human appetite control and weight regulation. Neurosci Biobehav Rev 2007;31:987–1002.CrossrefGoogle Scholar

108. Berridge KC, Robinson TE. Parsing reward. Trends Neurosci 2003;26:507–513.CrossrefGoogle Scholar

109. Avena NM, Rada P, Hoebel BG. Evidence for sugar addiction: Behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 2008;32:20–39.CrossrefGoogle Scholar

110. Kelley AE. Ventral striatal control of appetitive motivation: Role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 2004;27:765–776.CrossrefGoogle Scholar

111. Kelley AE, Baldo BA, Pratt WE, Will MJ. Corticostriatal-hypothalamic circuitry and food motivation: Integration of energy, action and reward. Physiol Behav 2005;86:773–795.CrossrefGoogle Scholar

112. Levine AS, Kotz CM, Gosnell BA. Sugars and fats: The neurobiology of preference. J Nutr 2003;133:831S–834S.CrossrefGoogle Scholar

113. Davis C, Strachan S, Berkson M. Sensitivity to reward: Implications for overeating and overweight. Appetite 2004;42:131–138.CrossrefGoogle Scholar

114. Beaver JD, Lawrence AD, van Ditzhuijzen J, Davis MH, Woods A, Calder AJ. Individual differences in reward drive predict neural responses to images of food. J Neurosci 2006;26:5160–5166.CrossrefGoogle Scholar

115. Karhunen LJ, Lappalainen RI, Vanninen EJ, Kuikka JT, Uusitupa MI. Regional cerebral blood flow during food exposure in obese and normal-weight women. Brain 1997;120:1675–1684.CrossrefGoogle Scholar

116. Rothemund Y, Preuschhof C, Bohner G, Bauknecht H, Klingebiel R, Flor H, et al.. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. NeuroImage 2007;37:410–421.CrossrefGoogle Scholar

117. Stoeckel LE, Weller RE, Cook EWIII, Twieg DB, Knowlton RC, Cox JE. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. Neuroimage 2008;41:636–647.CrossrefGoogle Scholar

118. Geliebter A, Ladell T, Logan M, Schneider T, Sharafi M, Hirsch J. Responsivity to food stimuli in obese and lean binge eaters using functional MRI. Appetite 2006;46:31–35.CrossrefGoogle Scholar

119. DelParigi A, Chen K, Salbe AD, Hill JO, Wing RR, Reiman EM, et al.. Persistence of abnormal neural responses to a meal in postobese individuals. Int J Obes Relat Metab Disord 2004;28:370–377.CrossrefGoogle Scholar

120. Gautier JF, Chen K, Salbe AD, Bandy D, Pratley RE, Heiman M, et al.. Differential brain responses to satiation in obese and lean men. Diabetes 2000;49:838–846.CrossrefGoogle Scholar

121. Gautier JF, Del Parigi A, Chen K, Salbe AD, Bandy D, Pratley RE, et al.. Effect of satiation on brain activity in obese and lean women. Obes Res 2001;9:676–684.CrossrefGoogle Scholar

122. Le DS, Pannacciulli N, Chen K, Del Parigi A, Salbe AD, Reiman EM, et al.. Less activation of the left dorsolateral prefrontal cortex in response to a meal: A feature of obesity. Am J Clin Nutr 2006;84:725–731.CrossrefGoogle Scholar

123. DelParigi A, Chen K, Salbe AD, Reiman EM, Tataranni PA. Sensory experience of food and obesity: A positron emission tomography study of the brain regions affected by tasting a liquid meal after a prolonged fast. Neuroimage 2005;24:436–443.CrossrefGoogle Scholar

124. Stice E, Spoor S, Bohon C, Veldhuizen MG, Small DM. Relation of reward from food intake and anticipated food intake to obesity: A functional magnetic resonance imaging study. J Abnorm Psychol 2008;117:924–935.CrossrefGoogle Scholar

125. Stice E, Spoor S, Bohon C, Small DM. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008;322:449–452.CrossrefGoogle Scholar

126. Ebersole KE, Dugas LR, Durazo-Arvizu RA, Adeyemo AA, Tayo BO, Omotade OO, et al.. Energy expenditure and adiposity in Nigerian and African-American women. Obesity 2008;16:2148–2154.CrossrefGoogle Scholar

127. Jeffery RW, Harnack LJ. Evidence implicating eating as a primary driver for the obesity epidemic. Diabetes 2007;56:2673–2676.CrossrefGoogle Scholar

128. Darby A, Hay P, Mond J, Quirk F, Buttner P, Kennedy L. The rising prevalence of comorbid obesity and eating disorder behaviors from 1995 to 2005. Int J Eat Disord 2009;42:104–108.CrossrefGoogle Scholar

129. Smith DE, Marcus MD, Lewis CE, Fitzgibbon M, Schreiner P. Prevalence of binge eating disorder, obesity, and depression in a biracial cohort of young adults. Ann Behav Med 1998;20:227–232.CrossrefGoogle Scholar

130. Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, et al.. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999;60:215–220.CrossrefGoogle Scholar

131. John U, Meyer C, Rumpf HJ, Hapke U. Relationships of psychiatric disorders with overweight and obesity in an adult general population. Obes Res 2005;13:101–109.CrossrefGoogle Scholar

132. Lamertz CM, Jacobi C, Yassouridis A, Arnold K, Henkel AW. Are obese adolescents and young adults at higher risk for mental disorders? A community survey. Obes Res 2002;10:1152–1160.CrossrefGoogle Scholar

133. Pagoto SL, Curtin C, Lemon SC, Bandini LG, Schneider KL, Bodenlos JS, et al.. Association between adult attention deficit/hyperactivity disorder and obesity in the US population. Obesity 2009;17:539–544.CrossrefGoogle Scholar

134. Waring ME, Lapane KL. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: Results from a national sample. Pediatrics 2008;122:e1–e6.CrossrefGoogle Scholar

135. Altfas JR. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry 2002;2:9–16.CrossrefGoogle Scholar

136. Braet C, Claus L, Verbeken S, Van Vlierberghe L. Impulsivity in overweight children. Eur Child Adolesc Psychiatry 2007;16:473–483.CrossrefGoogle Scholar

137. Bornstein SR, Schuppenies A, Wong ML, Licinio J. Approaching the shared biology of obesity and depression: The stress axis as the locus of gene-environment interactions. Mol Psychiatry 2006;11:892–902.CrossrefGoogle Scholar

138. Lissau I, Sorensen TI. Parental neglect during childhood and increased risk of obesity in young adulthood. Lancet 1994;343:324–327.CrossrefGoogle Scholar

139. MacMillan HL, Fleming JE, Streiner DL, Lin E, Boyle MH, Jamieson E, et al.. Childhood abuse and lifetime psychopathology in a community sample. Am J Psychiatry 2001;158:1878–1883.CrossrefGoogle Scholar

140. Molnar BE, Buka SL, Kessler RC. Child sexual abuse and subsequent psychopathology: Results from the National Comorbidity Survey. Am J Public Health 2001;91:753–760.CrossrefGoogle Scholar

141. Williamson DF, Thompson TJ, Anda RF, Dietz WH, Felitti V. Body weight and obesity in adults and self-reported abuse in childhood. Int J Obes Relat Metab Disord 2002;26:1075–1082.CrossrefGoogle Scholar

142. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Roux AV, et al.. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008;299:2751–2759.CrossrefGoogle Scholar

143. Ladwig KH, Marten-Mittag B, Lowel H, Doring A, Wichmann HE. Synergistic effects of depressed mood and obesity on long-term cardiovascular risks in 1510 obese men and women: Results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Int J Obes 2006;30:1408–1414.CrossrefGoogle Scholar

144. Vaccarino V, McClure C, Johnson BD, Sheps DS, Bittner V, Rutledge T, et al.. Depression, the metabolic syndrome and car diovascular risk. Psychosom Med 2008;70:40–48.CrossrefGoogle Scholar

145. Koponen H, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Vanhala M. Metabolic syndrome predisposes to depressive symptoms: A population-based 7-year follow-up study. J Clin Psychiatry 2008;69:178–182.CrossrefGoogle Scholar

146. Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmacher T. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 2003;37:193–220.CrossrefGoogle Scholar

147. Schwartz TL, Nihalani N, Jindal S, Virk S, Jones N. Psychiatric medication-induced obesity: A review. Obes Rev 2004;5:115–121.CrossrefGoogle Scholar

148. Rege S. Antipsychotic induced weight gain in schizophrenia: Mechanisms and management. Aust NZ J Psychiatry 2008;42:369–381.CrossrefGoogle Scholar

149. Virk S, Schwartz TL, Jindal S, Nihalani N, Jones N. Psychiatric medication induced obesity: An aetiologic review. Obes Rev 2004;5:167–170.CrossrefGoogle Scholar

150. Aichhorn W, Whitworth AB, Weiss EM, Marksteiner J. Second-generation antipsychotics: Is there evidence for sex differences in pharmacokinetic and adverse effect profiles? Drug Saf 2006;29:587–598.CrossrefGoogle Scholar

151. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al.. Antipsychotic-induced weight gain: A comprehensive research synthesis. Am J Psychiatry 1999;156:1686–1696.LinkGoogle Scholar

152. Fagiolini A, Chengappa KN. Weight gain and metabolic issues of medicines used for bipolar disorder. Curr Psychiatry Rep 2007;9:521–528.CrossrefGoogle Scholar

153. Henderson DC. Weight gain with atypical antipsychotics: Evidence and insights. J Clin Psychiatry 2007;68 (Suppl 12):18–26.CrossrefGoogle Scholar

154. Citrome LL, Holt RI, Zachry WM, Clewell JD, Orth PA, Karagianis JL, et al.. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics. Ann Pharmacother 2007;41:1593–1603.CrossrefGoogle Scholar